EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing

Noémie Deneyer iD, Pei-Ju Chin iD, Guillaume Bayon-Vicente iD, Pascale Beurdeley, Megan H Cleveland, Anne-Sophie Colinet, Stéphane Cruveiller, Marc Eloit, Shanaz Gilchrist, Noriko Hashiba, Christophe Lambert iD, Antonio Lembo und 13 weitere

Microbiology Spectrum · 03.11.2026 · 14 (11)

DOI: 10.1128/spectrum.00066-26 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Noémie Deneyer und 24 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Wavre, Belgium. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Herpesvirus 4, Human. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-throughput sequencing (HTS) is an agnostic virus detection technology that can replace or supplement the conventional adventitious virus assays used for safety testing of biologics. Transcriptomic HTS is particularly suitable for the detection of replicating viruses. We have evaluated the sensitivity of virus detection by transcriptomic HTS using targeted and non-targeted bioinformatics analysis of infected cells spiked into a background of uninfected cells, mimicking material representing a test sample from product manufacturing. Eight laboratories tested a mix of Raji cells (expressing Epstein-Barr virus [EBV] RNAs without virus production) and EBV-negative Ramos cells at ratios ranging from 0.5 to 0.00005. Seven laboratories performed the analysis using different HTS protocols, while the eighth laboratory quantified EBV RNA recovery in all extracted samples by quantifying EBNA-1 by RT-ddPCR assay. All participants detected EBV transcripts at a 0.001 ratio with the targeted analysis and a 0.01 ratio with the non-targeted analysis (i.e., one infected cell in 100 uninfected cells), with four laboratories achieving detection at the 0.0001 ratio for both analysis. The results of the spiking studies demonstrated the capabilities of transcriptomic HTS for adventitious virus detection in cell lines used for the production of biologics, and highlight that optimization in the workflow can improve HTS virus detection. IMPORTANCE High-throughput sequencing (HTS) is currently recognized as a powerful technology for broad virus detection. While HTS can be considered an alternative method to replace or supplement the conventional adventitious virus detection assays for testing biologics, its routine implementation has been challenging due to the complexities of the HTS workflow, including the matrix of the test sample, selection of HTS methodology (viromic, genomic, or transcriptomic), and variability in the protocols (from sample preparation to bioinformatic analysis). The study demonstrated the performance and capabilities of the transcriptomic HTS approach for the detection of virus-infected cells using different workflows presented by seven laboratories. The study indicated that regardless of the protocol used, all participants detected viral RNA at the 0.01 ratio; however, certain HTS protocols demonstrated better sensitivity of viral detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingHerpesvirus 4, HumanHumansRNA, ViralCell LineSensitivity and SpecificityTranscriptomeGene Expression ProfilingComputational BiologyEpstein-Barr Virus Nuclear AntigensEpstein-Barr Virus Infections

Stichwörter der Autor:innen

adventitious virusesepstein-barr virushigh-throughput sequencinghuman herpesvirus 4raji cell lineramos lineviral transcriptomics

Substanzen

RNA, ViralEpstein-Barr Virus Nuclear Antigens

Autor:innen und Institutionen

  • GSK, Wavre, Belgium.
  • Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Review, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • GSK, Rixensart, Belgium.
  • PathoQuest, Paris, France.
  • Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.
  • Sanofi, Toronto, Ontario, Canada.

ORCID-Profile: Noémie Deneyer, Pei-Ju Chin, Guillaume Bayon-Vicente, Christophe Lambert, Arifa S Khan

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Deneyer, N., Chin, P. J., Bayon-Vicente, G., Beurdeley, P., Cleveland, M. H., Colinet, A. S., Cruveiller, S., Eloit, M., Gilchrist, S., Hashiba, N., Lambert, C., Lembo, A., Leong, K. W., Micheals, B., Moreira, S., Nakashima, R., Olgiati, S., Salehi, N., Sun, Q., …, & Khan, A. S. (2026). A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.00066-26

Vancouver

Deneyer N, Chin PJ, Bayon-Vicente G, Beurdeley P, Cleveland MH, Colinet AS, et al. A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.00066-26

BibTeX
@article{Deneyer2026,
  author = {Deneyer, Noémie and Chin, Pei-Ju and Bayon-Vicente, Guillaume and Beurdeley, Pascale and Cleveland, Megan H and Colinet, Anne-Sophie and Cruveiller, Stéphane and Eloit, Marc and Gilchrist, Shanaz and Hashiba, Noriko and Lambert, Christophe and Lembo, Antonio and Leong, Ka-Wai and Micheals, Brandye and Moreira, Sandrine and Nakashima, Reiko and Olgiati, Simone and Salehi, Nasrin and Sun, Qinyu and Uchida, Kazuhisa and Vandeputte, Olivier and Yuan, Yuzhe and Yusa, Keisuke and Zanda, Valeria Maria and Khan, Arifa S},
  title = {A collaborative study evaluating the detection of virus-infected cells by transcriptomic high-throughput sequencing},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1128/spectrum.00066-26}
}
Kostenlos starten →